Abstract:Each of the three BAFF receptors (BCMA, TACI and BR3) has a non‐redundant role in determining the ultimate lymphocyte profile of the host, including the distribution of B cell subsets and the expansion of Foxp3+ cells. This may have clinically relevant ramifications in that the degree that a candidate therapeutic agent blocks engagement of any given individual BAFF receptor may affect its clinical utility. BAFF, a vital B cell survival and differentiation factor, has three receptors: B‐cell maturation antigen (BCMA), transmembrane activator and CAML interactor (TACI) and BR3. Although B cells are greatly reduced in B6.Baff−/− (which harbour no BAFF) and B6.Br3−/− mice (which harbour supra‐normal levels of BAFF), the distributions of B cell subsets and relationships between Foxp3+ and CD4+ cells in these mice differ. Using a large panel of B6 congenic knockout and/or transgenic mice, we demonstrate that (1) supra‐normal levels of BAFF per se do not explain the phenotypic differences between B6.Baff−/− and B6.Br3−/− mice; (2) B cells are expanded in B6.Taci−/− mice, with preferential expansion of follicular (FO) B cells at the expense of CD19+CD21−/loCD23−/lo B cells but without the preferential expansion of Foxp3+ cells observed in B6 mice bearing a Baff transgene; (3) despite no expansion in total B cells, percentages of FO B cells and marginal zone B cells are higher and percentages of CD19+CD21−/loCD23−/lo B cells are lower in young B6.Bcma−/− mice, consistent with the inability of B6.Br3−/−.Taci−/− mice to recapitulate the B cell profile of B6.Baff−/− mice; and (4) percentages of Foxp3+ cells in B6.Br3−/−.Taci−/− mice are intermediate between those in B6.Br3−/− and B6.Taci−/− mice despite the B cell profile of B6.Br3−/−.Taci−/− mice strongly resembling that of B6.Br3−/− mice. Collectively, our findings point to a non‐redundant role for each of the BAFF receptors in determining the ultimate lymphocyte profile of the host. This may have clinically relevant ramifications in that the degree that a candidate therapeutic agent blocks engagement of any given individual BAFF receptor may affect its clinical utility.

Baff Promotes Th17 Cells And Aggravates Experimental Autoimmune Encephalomyelitis

BAFF Binding to T Cell-Expressed BAFF-R Promotes Follicular Helper T Cell Proliferation and GC B Cell Responses

B Cell Activating Factor (baff) Induces the Transcription of Recombination-Activating Genes in Transitional Stage 1 B Cells

Blockade of B-cell Activating Factor with TACI-IgG Effectively Reduced Th1 and Th17 Cells but Not Memory T Cells in Experimental Allergic Encephalomyelitis Mice

Contributions of each of the BAFF receptors to the lymphocyte profiles in C57BL/6 mice

BAFF suppresses IL-15 expression in B cells.

Mouse Cd11b(+)Gr-1(+) Myeloid Cells Can Promote Th17 Cell Differentiation And Experimental Autoimmune Encephalomyelitis

The Function of BAFF on T Helper Cells in Autoimmunity.

BAFF promotes follicular helper T cell development and germinal center formation through BR3 signal

Enhanced T cell proliferation, Th17 differentiation and unaltered IL-10 production lead to marginally enhanced development of experimental autoimmune encephalomyelitis in EBI3-deficient mice (114.12)

Cd4(+)T Cell Specific B7-H1 Selectively Inhibits Proliferation Of Naive T Cells And Th17 Differentiation In Experimental Autoimmune Encephalomyelitis

BACE1: a novel player in the pathogenesis of Th17 cells in EAE

Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.

BTN2A2-Ig protein inhibits the differentiation of pathogenic Th17 cells and attenuates EAE in mice

The Unknown Aspect of BAFF: Inducing IL-35 Production by a CD5+CD1dhiFcγRIIbhi Regulatory B-Cell Subset in Lupus.

EncephalomyelitisDevelopment of Autoimmune Mice Lead to Marginally Enhanced Responses in EBV-Induced Gene 3-Deficient Increased Th17 and Regulatory T Cell

B cell activating factor (BAFF) selects IL-10−B cells over IL-10+B cells during inflammatory responses

BAFF overexpression in triple-negative breast cancer promotes tumor growth by inducing IL-10-secreting regulatory B cells that suppress anti-tumor T cell responses

BAFF activates Erk1/2 promoting cell proliferation and survival by Ca 2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells

T Follicular Helper-Like Cells Are Involved in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.

TLR9 mediated regulatory B10 cell amplification following sub-total body irradiation: Implications in attenuating EAE.